Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT00772343

Completed

Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

Diarrhea | Clostridium Difficile Infection
NCT07142356

Recruiting

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension
NCT06751966

Recruiting

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Colorectal Cancer (CRC)
NCT06306196

Recruiting

Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children

Hepatitis E Virus Infection
NCT05183516

Not yet recruiting

Tdap and Biomarkers of Alzheimer's Disease

Alzheimer Disease, Late Onset
NCT05172193

Recruiting

Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

COVID-19
NCT05125770

Recruiting

Study on the Fetal Safety of New Coronavirus Vaccination for Couples During the Peri-pregnancy Period

Perinatal
NCT04934111

Recruiting

Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19 (COVAC-Uganda)

COVID-19
NCT03430037

Enrolling by invitation

Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women (AFFIRM)

Frail Elderly Syndrome
NCT06961266

Terminated

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

Narcolepsy
NCT06907511

Active, not recruiting

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

Healthy Volunteers | Pandemic Influenza Immunization
NCT01861938

Withdrawn

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Metastatic Disease | High Risk HLA-A2+ Melanoma
NCT05013983

Withdrawn

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

COVID-19
NCT06763783

Enrolling by invitation

Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases (HZ-REUMA)

Spondylarthropathies | Systemic Vasculitis | Psoriatic Arthritis | SLE | Scleroderma | Polymyalgia Rheumatica (PMR) | Polyarthritis | Giant Cell Arteritis (GCA) | Juvenile Chronic Arthritis
NCT04199689

Active, not recruiting

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Papillomavirus Infections
NCT04736134

Completed

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Healthy Participants

Healthy Participants
NCT06334510

Completed

Evaluate the Safety and Efficacy of Quadrivalent Influenza in Real-world Situations.

GCP
NCT04333732

Completed

CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION (CROWN CORONA)

COVID 19
NCT02406729

Active, not recruiting

Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine

Dengue
NCT00082641

Completed

Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer

Breast Cancer
NCT00380367

Completed

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Papillomavirus Infections
NCT04651790

Active, not recruiting

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL)

Covid19 | Vaccines
NCT05422898

Completed

Discussing COVID-19 Vaccines in Private Facebook Groups

COVID-19
NCT01266616

Completed

Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults

HIV Infections
NCT01531530

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Shigella
NCT00300612

Completed

Vaccine Treatment for Advanced Malignant Melanoma

Malignant Melanoma
NCT00463476

Completed

Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine

Japanese Encephalitis
NCT02946177

Unknown

Effect of Influenza Vaccination on Donor Egg Recipient Outcomes (DE-FluVac)

Infertility | Recurrent Miscarriage
NCT02757950

Completed

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

Diphtheria
NCT01632332

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

HER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer
NCT02475278

Completed

Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine

Healthy Participants | Norovirus
NCT01103687

Completed

Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults

HIV Infections
NCT00393523

Completed

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

Hepatitis B
NCT00534248

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Shingles
NCT00322361

Completed

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Hepatitis B | Hepatocellular Carcinoma
NCT00616421

Completed

Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children

Meningococcal Infections
NCT00161928

Completed

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Meningitis, Meningococcal
NCT00128219

Completed

Prevention of GBS Colonization Via Immunity

Beta Haemolytic Streptococcal Infection
NCT01707069

Completed

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Allergic Rhinoconjunctivitis
NCT00808405

Completed

GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women (PK/GUD)

Genital Herpes
NCT00006387

Completed

Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer

Colorectal Cancer | Pancreatic Cancer
NCT01491087

Completed

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Pertussis | Tetanus | Diphtheria | Polio
NCT00004604

Completed

Biological Therapy in Treating Patients With Metastatic Cancer

Testicular Germ Cell Tumor | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Metastatic Cancer | Liver Cancer
NCT01136161

Completed

Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection

Tuberculosis | Latent Tuberculosis Infection
NCT01073306

Completed

Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

Dengue Virus
NCT01465477

Unknown

Influenza Vaccination in Fibromyalgia Patients

Fibromyalgia Syndrome
NCT01013675

Completed

Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly

Influenza Vaccines
NCT00023985

Completed

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer
NCT01140139

Completed

Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions (Vac09)

HIV-1
NCT00119197

Completed

Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata

Cholera

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations